132 related articles for article (PubMed ID: 26554827)
1. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
[TBL] [Abstract][Full Text] [Related]
2. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
3. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.
Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM
Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282
[TBL] [Abstract][Full Text] [Related]
4. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
5. DNp73 improves generation efficiency of human induced pluripotent stem cells.
Lin Y; Cheng Z; Yang Z; Zheng J; Lin T
BMC Cell Biol; 2012 Mar; 13():9. PubMed ID: 22449255
[TBL] [Abstract][Full Text] [Related]
6. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.
Dulloo I; Hooi PB; Sabapathy K
Cell Cycle; 2015; 14(22):3533-9. PubMed ID: 26267146
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms, function and clinical applications of DNp73.
Di C; Yang L; Zhang H; Ma X; Zhang X; Sun C; Li H; Xu S; An L; Li X; Bai Z
Cell Cycle; 2013 Jun; 12(12):1861-7. PubMed ID: 23708520
[TBL] [Abstract][Full Text] [Related]
9. Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs.
Bunjobpol W; Dulloo I; Igarashi K; Concin N; Matsuo K; Sabapathy K
Cell Death Differ; 2014 Aug; 21(8):1240-9. PubMed ID: 24722210
[TBL] [Abstract][Full Text] [Related]
10. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
Emmrich S; Wang W; John K; Li W; Pützer BM
Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
Liu T; Wu X; Chen T; Luo Z; Hu X
Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
[No Abstract] [Full Text] [Related]
13. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
14. p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.
Fernandez-Alonso R; Martin-Lopez M; Gonzalez-Cano L; Garcia S; Castrillo F; Diez-Prieto I; Fernandez-Corona A; Lorenzo-Marcos ME; Li X; Claesson-Welsh L; Marques MM; Marin MC
Cell Death Differ; 2015 Aug; 22(8):1287-99. PubMed ID: 25571973
[TBL] [Abstract][Full Text] [Related]
15. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327
[TBL] [Abstract][Full Text] [Related]
16. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
17. DNp73 a matter of cancer: mechanisms and clinical implications.
Buhlmann S; Pützer BM
Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
[TBL] [Abstract][Full Text] [Related]
18. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
19. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
